Onyx Biotec

{
  "main_header": {
    "sid": 10039457,
    "name": "Onyx Biotec",
    "stock_name": "Onyx Biotec",
    "full_name": "Onyx Biotec Ltd",
    "name_url": "stocks-analysis/onyx-biotec",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.70",
    "chg": 2.7,
    "chgp": "7.3%",
    "dir": 1,
    "prev_price": "37.00",
    "mcapval": "71.98 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ONYX",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0WVU01018",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": 14000,
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onyx-biotec-10039457-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3703909",
        "imagepath": "",
        "date": "2025-11-15 00:18:00",
        "description": "As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company.\n\nIn the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail..."
      },
      {
        "title": "How has been the historical performance of Onyx Biotec?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-onyx-biotec-3699883",
        "imagepath": "",
        "date": "2025-11-13 23:54:11",
        "description": "Answer:\nThe historical performance of Onyx Biotec shows a consistent growth trajectory in net sales and profitability over the past three fiscal years.\n\nBreakdown:\nOnyx Biotec's net sales increased from 39.48 Cr in Mar'23 to 53.75 Cr in Mar'24, and further to 61.95 Cr in Mar'25, indicating a strong upward trend. Total operating income mirrored this growth, reaching 61.95 Cr in Mar'25. The company's total expenditure also rose, from 35.03 Cr in Mar'23 to 51.61 Cr in Mar'25, primarily driven by an increase in raw material costs and employee expenses. Operating profit (PBDIT) improved significantly from 4.58 Cr in Mar'23 to 11.51 Cr in Mar'25, with a corresponding increase in the operating profit margin from 11.27% to 16.69%. Profit before tax followed suit, rising from 2.55 Cr in Mar'23 to 6.48 Cr in Mar'25, while profit after tax also saw a substantial increase from 1.84 Cr to 4.95 Cr during the same period...."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3695490",
        "imagepath": "",
        "date": "2025-11-13 00:27:09",
        "description": "As of 12-Nov, Onyx Biotec Ltd's stock price is currently at 42.80, reflecting an increase of 0.8, or 1.9%. The stock has shown a strong performance today, outperforming its sector by 0.92%. Additionally, the delivery volume has significantly increased by 1223.53% compared to the 5-day average, indicating rising investor participation. While the stock is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 7.27%, which is notably higher than the Sensex's increase of 1.09%, suggesting a positive momentum in the short term. However, the year-to-date performance shows a decline of 28.07%, contrasting with the Sensex's gain of 9.44%.\n\nIn the broader market context, Onyx Biotec's recent rise can be attributed to its strong short-term performance relative to the benchmark, as it has outperformed the Sensex over..."
      }
    ],
    "total": 34,
    "sid": "10039457",
    "stock_news_url": "https://www.marketsmojo.com/news/onyx-biotec-10039457"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Onyx Biotec falling/rising?

2025-11-15 00:18:00

As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company. In the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail...

Read full news article

How has been the historical performance of Onyx Biotec?

2025-11-13 23:54:11

Answer: The historical performance of Onyx Biotec shows a consistent growth trajectory in net sales and profitability over the past three fiscal years. Breakdown: Onyx Biotec's net sales increased from 39.48 Cr in Mar'23 to 53.75 Cr in Mar'24, and further to 61.95 Cr in Mar'25, indicating a strong upward trend. Total operating income mirrored this growth, reaching 61.95 Cr in Mar'25. The company's total expenditure also rose, from 35.03 Cr in Mar'23 to 51.61 Cr in Mar'25, primarily driven by an increase in raw material costs and employee expenses. Operating profit (PBDIT) improved significantly from 4.58 Cr in Mar'23 to 11.51 Cr in Mar'25, with a corresponding increase in the operating profit margin from 11.27% to 16.69%. Profit before tax followed suit, rising from 2.55 Cr in Mar'23 to 6.48 Cr in Mar'25, while profit after tax also saw a substantial increase from 1.84 Cr to 4.95 Cr during the same period....

Read full news article

Why is Onyx Biotec falling/rising?

2025-11-13 00:27:09

As of 12-Nov, Onyx Biotec Ltd's stock price is currently at 42.80, reflecting an increase of 0.8, or 1.9%. The stock has shown a strong performance today, outperforming its sector by 0.92%. Additionally, the delivery volume has significantly increased by 1223.53% compared to the 5-day average, indicating rising investor participation. While the stock is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 7.27%, which is notably higher than the Sensex's increase of 1.09%, suggesting a positive momentum in the short term. However, the year-to-date performance shows a decline of 28.07%, contrasting with the Sensex's gain of 9.44%. In the broader market context, Onyx Biotec's recent rise can be attributed to its strong short-term performance relative to the benchmark, as it has outperformed the Sensex over...

Read full news article

View All News